Clinical Trial

New study backs hair regrowth reduction claims

New study backs hair regrowth reduction claims

By Andrew MCDOUGALL

A new independent clinical study demonstrates a substantial reduction in hair regrowth following use of the no!no! Hair product, much to the joy of manufacturer Radiancy, a Photomedex subsidiary.

Cosmetics research could be subject to IND requirements

Cosmetics research could be subject to IND requirements

By Lucy Whitehouse

The Food and Drug Administration (FDA) has extended the comment period on guidance which could require cosmetics research to secure an Investigational New Drug (IND) before carrying out clinical trials.

Spotlight

Follow us

Featured Events

View more

Products

View more

Webinars

Featured Suppliers

All suppliers